Skip to main content

CRISPR Archives

When science spills onto social media

Apr. 21, 2022—Vanderbilt researchers report that social media posts can offer insights into how the public feels about genome editing, with stances varying across platforms and differing from those of academics and policy makers.

Read more


CRISPR screen identifies new anti-inflammatory drug target

Nov. 11, 2021—A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

Read more


Vanderbilt Prize winner Doudna advocates caution in human germline editing

Jul. 29, 2021—It is now possible to “edit” the human germline — the genetic cargo carried in sperm and eggs and which is passed to the next generation — in a way that snips out the mutations which cause inherited disease.

Read more


Nobel laureate Doudna set for next Discovery Lecture

Jul. 7, 2021—Nobel laureate Jennifer Doudna, PhD, winner of the 2020 Vanderbilt Prize in Biomedical Science, will deliver the next web-based Discovery Lecture on Thursday, July 22.

Read more


Vanderbilt Prize winner Doudna awarded Nobel Prize in Chemistry

Oct. 7, 2020—University of California, Berkeley, biochemist Jennifer Doudna, PhD, recipient of the 2020 Vanderbilt Prize in Biomedical Science, has been awarded the 2020 Nobel Prize in Chemistry.

Read more


UC Berkeley’s Doudna named to receive Vanderbilt Prize

Mar. 18, 2020—Jennifer Doudna, PhD, who led development of the revolutionary genome editing technology known as CRISPR-Cas9, is the recipient of the 2020 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.

Read more


Studying cellular deliveries

Oct. 25, 2018—Vanderbilt researchers have characterized the functional transfer of long RNAs between colorectal cancer cells — a form of cell-cell communication that may contribute to cancer aggressiveness.

Read more


Landmark report urges caution before releasing gene drive-modified organisms

Jun. 9, 2016—A new report released this week raises questions about “gene drives,” a biological process that can profoundly and rapidly alter the characteristics of entire species.

Read more


A “CRISPR” way to study disease

Jun. 11, 2015—Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases.

Read more


Discovery Lecturer outlines new genome editing technique

Jan. 15, 2015—A mere 30 months since it was first described in the online edition of Science magazine, a new genome editing technique has, by many accounts, revolutionized the study of genes and disease.

Read more


New technique accelerates genome editing process

Aug. 21, 2014—It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more